Significance of Intraventricular Hemorrhage in Acute Intracerebral Hemorrhage: Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial Results

Background and Purpose— Intraventricular hemorrhage (IVH) with spontaneous intracerebral hemorrhage indicates a poor prognosis but uncertainty exists over the pattern of association. We aimed to elucidate risk associations of IVH and outcome in the Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial (INTERACT2) data set. Methods— INTERACT2 was an international prospective, open-blinded end point, randomized controlled trial in 2839 patients with intracerebral hemorrhage (<6 hours) with elevated systolic blood pressure randomly assigned to intensive (target systolic blood pressure <140 mm Hg) or guideline-based (systolic blood pressure <180 mm Hg) blood pressure management. Associations of baseline IVH in 740 of 2613 (28%) patients and poor outcomes (death and major disability defined on the modified Rankin Scale) at 90 days were determined in linear and logistic regression models. Results— Patients with IVH were significantly older and with greater neurological impairment, history of ischemic stroke, and larger hematomas more often deep hemisphere located at presentation, after adjustment for other baseline variables. Death or major disability occurred in 66% with IVH versus 49% in intracerebral hemorrhage–alone patients (adjusted odds ratio, 1.68; 95% confidence interval, 1.38–2.06; P<0.01). Associations of IVH volume and clinical outcomes were strong and near continuous. Adjusted analyses by thirds of IVH volume indicate thresholds of ≈5 and 10 mL for significantly increased odds of death and death or major disability, respectively. Conclusions— A strong association exists between the amount of IVH and poor outcome in intracerebral hemorrhage. An IVH volume of 5 to 10 mL emerges as a significant threshold for decision making on prognosis in these patients. Clinical Trial Registration— URL: http://www.clinicaltrials.gov. Unique identifier: NCT00716079.

[1]  A. Alexandrov,et al.  Fibrinolysis for Intraventricular Hemorrhage: An Updated Meta-Analysis and Systematic Review of the Literature , 2014, Stroke.

[2]  D. Hanley,et al.  Intraventricular Thrombolysis in Intracerebral Hemorrhage Requiring Ventriculostomy: A Decade-Long Real-World Experience , 2014, Stroke.

[3]  D. Hanley,et al.  A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Phase III Study of Clot Lysis Evaluation of Accelerated Resolution of Intraventricular Hemorrhage (CLEAR III) , 2014, International journal of stroke : official journal of the International Stroke Society.

[4]  Andrew E Moran,et al.  Global and regional burden of first-ever ischaemic and haemorrhagic stroke during 1990–2010: findings from the Global Burden of Disease Study 2010 , 2013, The Lancet. Global health.

[5]  M. Woodward,et al.  Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. , 2013, The New England journal of medicine.

[6]  D. Hanley,et al.  Occurrence and impact of intracranial pressure elevation during treatment of severe intraventricular hemorrhage* , 2012, Critical care medicine.

[7]  S. Cavalheiro,et al.  Prognostic Value of Intraventricular Bleeding in Spontaneous Intraparenchymal Cerebral Hemorrhage of Small Volume: A Prospective Cohort Study , 2012, Neurosurgery.

[8]  S. Schwab,et al.  Intraventricular Fibrinolysis for Intracerebral Hemorrhage with Severe Ventricular Involvement , 2011, Neurocritical care.

[9]  N. Miyamatsu,et al.  A priority treatment of the intraventricular hemorrhage (IVH) should be performed in the patients suffering intracerebral hemorrhage with large IVH , 2009, Clinical Neurology and Neurosurgery.

[10]  D. Hanley.  Intraventricular Hemorrhage: Severity Factor and Treatment Target in Spontaneous Intracerebral Hemorrhage , 2009, Stroke.

[11]  S. Mayer,et al.  Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. , 2008, The New England journal of medicine.

[12]  A David Mendelow,et al.  Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial , 2005, The Lancet.

[13]  A. Dávalos,et al.  Early neurologic deterioration in intracerebral hemorrhage , 2004, Neurology.

[14]  S. Tuhrim,et al.  Volume of ventricular blood is an important determinant of outcome in supratentorial intracerebral hemorrhage. , 1999, Critical care medicine.

[15]  M. Frankel,et al.  Predictors of early deterioration and mortality in black Americans with spontaneous intracerebral hemorrhage. , 1995, Stroke.

[16]  W. Rand,et al.  Prognostic significance of ventricular blood in supratentorial hemorrhage , 1990, Neurology.

[17]  H. Schouten,et al.  Interobserver agreement for the assessment of handicap in stroke patients. , 1988, Stroke.

[18]  Alan D. Lopez,et al.  The Global Burden of Disease Study , 2003 .

[19]  J. Broderick,et al.  Early hemorrhage growth in patients with intracerebral hemorrhage. , 1997, Stroke.

[20]  R. Bloch,et al.  Interobserver agreement for the assessment of handicap in stroke patients. , 1988, Stroke.